Graham Holdings Co. (GHC) - Q2 2025 10-Q Summary
Business Context and Reporting Period
This summary covers the quarterly period ended June 30, 2025. Graham Holdings Company is a diversified holding company with operations in education (Kaplan), television broadcasting (Graham Media Group), manufacturing, healthcare (Graham Healthcare Group), automotive dealerships, and other businesses including media and retail.
Key Financial Metrics
| Metric (in thousands) | Q2 2025 | Q2 2024 | YTD 2025 | YTD 2024 |
|---|---|---|---|---|
| Operating Revenues | $1,215,772 | $1,185,280 | $2,381,687 | $2,337,942 |
| Income from Operations | $72,751 | $25,911 | $120,224 | $61,353 |
| Net Income (Attributable to GHC) | $36,749 | $(21,040) | $60,643 | $103,340 |
| Diluted EPS | $8.35 | $(4.79) | $13.81 | $23.11 |
| Operating Cash Flow (YTD) | $140,810 | $53,108 | $140,810 | $53,108 |
| Total Debt | $816,375 | $748,192 | $816,375 | $748,192 |
| Cash & Equivalents | $176,223 | $260,852 | $176,223 | $260,852 |
Note: Debt and Cash figures represent balances as of June 30, 2025, and December 31, 2024 respectively, as comparative Q2 2024 balance sheet data is not explicitly provided in the text.
Material Changes vs. Prior Period
- Revenue Growth: Q2 2025 revenue increased 3% year-over-year, driven by growth in Education, Healthcare, and Other Businesses, partially offset by declines in Television Broadcasting, Manufacturing, and Automotive.
- Operating Income Surge: Operating income rose significantly to $72.8 million in Q2 2025 from $25.9 million in Q2 2024. This improvement is largely due to the absence of a $26.3 million goodwill impairment charge recorded in Q2 2024 at World of Good Brands (WGB).
- Net Income Volatility: While Q2 2025 reported a net income of $36.7 million compared to a loss of $21.0 million in Q2 2024, YTD 2025 net income ($60.6 million) was lower than YTD 2024 ($103.3 million). This decline is primarily attributed to a $67.6 million interest expense in 2025 related to adjusting the fair value of mandatorily redeemable noncontrolling interests, compared to $75.4 million in 2024, and significantly lower gains on marketable equity securities ($32.3 million in 2025 vs. $123.8 million in 2024).
- Segment Performance:
- Healthcare: Revenue up 37% and operating income up 97% due to growth at CSI Pharmacy and home health services.
- Education: Revenue up 3%; operating income up 31% driven by Higher Education and Supplemental Education.
- Television Broadcasting: Revenue down 8% due to declines in political and retransmission advertising.
- Automotive: Revenue down 8% due to lower new and used vehicle sales.
Guidance, Outlook, and Risks
- Capital Expenditures: Management estimates 2025 capital expenditures will range between $85 million and $95 million.
- Dividends: The Company expects to pay a total dividend of $7.20 per share in 2025.
- Acquisitions & Dispositions:
- On July 15, 2025, the Manufacturing segment (Hoover) acquired Arconic Architectural Products, assuming ~$105 million in net pension obligations.
- WGB operations are expected to be substantially shut down by the end of Q3 2025 following the sale of various websites.
- Leadership Changes: Co-CEOs of Graham Healthcare Group (GHG) have stepped down, with a transition period underway.
- Tax Legislation: New U.S. tax legislation enacted July 4, 2025, is expected to significantly reduce federal taxable income for 2025 due to changes in R&D treatment and accelerated capital expenditure deductions.
- Risks: Management cites macroeconomic risks related to tariff policies and potential economic slowdowns as the most meaningful risks. There is also uncertainty regarding future retransmission revenue trends due to cord-cutting.
Investor Verification Checklist
- Non-Controlling Interest Adjustments: Verify the impact of the $67.6 million interest expense related to the fair value adjustment of mandatorily redeemable noncontrolling interests (GHC One/Two) on net income and cash flow.
- Investment Portfolio Volatility: Review the $32.3 million gain on marketable equity securities (YTD 2025) versus the $123.8 million gain in the prior year, noting the significant unrealized gains ($657.5 million) held in the portfolio.
- Healthcare Segment Growth: Assess the sustainability of the 37% revenue growth in the Healthcare segment, specifically the expansion of CSI Pharmacy infusion treatments.
- WGB Wind-Down: Monitor the timeline and costs associated with the complete shutdown of World of Good Brands operations by Q3 2025.
- Debt Maturity: Note the $400 million senior unsecured notes due June 1, 2026, and the Company's liquidity position to service this debt.